NCT02121301View on ClinicalTrials.gov

A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES)

PHASE2CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Keratoconjunctivitis Sicca
Interventions
DRUG

Low Dose 0.155µg/mL SkQ1 ophthalmic solution

eyedrops

DRUG

High Dose 1.55µg/mL SkQ1 ophthalmic solution

eyedrops

DRUG

Placebo (Vehicle) opthalmic solution

eyedrops

Trial Locations (1)

01841

Lawrence General Hospital, Andover

Sponsors

Lead Sponsor

Mitotech, SA
All Listed Sponsors
collaborator

ORA, Inc.

INDUSTRY

lead

Mitotech, SA

INDUSTRY